Bel Marra Health | Dementia and cognitive decline delayed with cardiovascular disease and diabetes prevention: Study Bel Marra Health A study found that living with heart problems could increase your risk of dementia or Alzheimer's disease. The study examined data from 1,000 people who were followed for 11 years. The results, published in Circulation, revealed that among the group 32 ... Research: Dementia rates declining Dementia rates decline sharply among senior citizens Dementia Rates Might Be Decreasing, And Scientists Have No Idea Why |
Month: November 2016
ONS names dementia and Alzheimer’s as leading cause of death for first time – Nursing in Practice
ONS names dementia and Alzheimer's as leading cause of death for first time Nursing in Practice Figures from the Office for National Statistics (ONS) have shown that dementia and Alzheimer's disease are now the leading cause of death in England and Wales. This replaces ischaemic heart disease as the leading cause of death and is related to an ... |
Taking a Virtual Dementia Tour – 9NEWS.com
9NEWS.com | Taking a Virtual Dementia Tour 9NEWS.com The Alzheimer's Association is working with Vivage Senior Living to get people to take the Second Wind Dreams Virtual Dementia Tour. People are fitted with special glasses, headphones, gloves, and other measures to allow them to experience what life is ... |
Arizona nursing home takes in orphaned kittens to help Alzheimer’s … – Daily Mail
Daily Mail | Arizona nursing home takes in orphaned kittens to help Alzheimer's ... Daily Mail As part of the partnership between the nursing home and an animal center in Arizona, residents are required to bottle feed and socialize with Peaches and Turtle ... Orphaned Kittens Bring Immeasurable Joy To Dementia Patients ... |
Alzheimer’s Association Grant Furthers Research into Obesity, Brain Aging and Dementia – Alzheimer’s News Today
Alzheimer's News Today | Alzheimer's Association Grant Furthers Research into Obesity, Brain Aging and Dementia Alzheimer's News Today The Alzheimer's Association has awarded a $118,673 grant to a researcher at Boston University School of Medicine to study how obesity affects brain aging and, potentially, a person's risk of Alzheimer's disease or dementia. The researcher, Claudia ... Alzheimer's disease: Dementia prevalence is declining among US adults Occupational therapy fails to aid functioning in Alzheimer's patients Scientists created a mobile game to help detect the early onset of dementia |
Orphaned Kittens Bring Immeasurable Joy To Dementia Patients – Huffington Post
Huffington Post | Orphaned Kittens Bring Immeasurable Joy To Dementia Patients Huffington Post Countless orphaned kittens are finding the love they need in an unlikely place ― the arms of dementia patients who need a little comfort of their own. Last year, those at the Pima Animal Care Center in Tucson, Arizona say they took in over 2,100 ... |
Promising Alzheimer’s Drug Doesn’t Help Dementia Patients – NBCNews.com
NBCNews.com | Promising Alzheimer's Drug Doesn't Help Dementia Patients NBCNews.com The drug, called solanezumab, was designed to clear the brain-clogging amyloid plaques that are one main physical symptom of Alzheimer's. But patients with early dementia due to Alzheimer's didn't seem to get much benefit from the drug, the company ... Dismay as Alzheimer's drug fails in clinical trials Results for Solanezumab in Mild Dementia of Alzheimer's Disease Announced Hopes for new Alzheimer's drug dashed |
Dismay as Alzheimer’s drug fails in clinical trials – The Guardian
The Guardian | Dismay as Alzheimer's drug fails in clinical trials The Guardian In a statement, the company said: “Lilly will not pursue regulatory submissions for solanezumab for the treatment of mild dementia due to Alzheimer's disease.” Lilly's shares plunged 14% on Wednesday before markets opened. The same drug failed in a ... Promising Alzheimer's Drug Doesn't Help Dementia Patients Alzheimer's drug 'disappointment': Widely anticipated drug to treat disease fails in trial Eli Lilly's Experimental Alzheimer's Drug Failed in Large Trial |
Alzheimer’s drug ‘disappointment’: Widely anticipated drug to treat disease fails in trial – Express.co.uk
Express.co.uk | Alzheimer's drug 'disappointment': Widely anticipated drug to treat disease fails in trial Express.co.uk It failed to slow cognitive decline in people with mild Alzheimer's disease. If it had been successful, it would have been the first new treatment for dementia since 2003, and the first to slow the progression of Alzheimer's. Jeremy Hughes, chief ... Dismay as Alzheimer's drug fails in clinical trials Promising Alzheimer's Drug Doesn't Help Dementia Patients Hopes for new Alzheimer's drug dashed |
Eli Lilly Alzheimer’s Drug Fails Trial – Wall Street Journal
Wall Street Journal | Eli Lilly Alzheimer's Drug Fails Trial Wall Street Journal Alzheimer's is a progressive form of dementia that causes memory, thinking and behavioral problems with symptoms worsening as someone ages. Phase 3 clinical trials are typically the last phase before a drug seeks approval from the Food and Drug ... Hopes for new Alzheimer's drug dashed Lilly's solanezumab flunks late-stage study in Alzheimer's-related dementia; shares down 14% premarket; Biogen ... Eli Lilly Shares Plunge as Alzheimer's Trial Fails to Achieve Goals |